The role of nuclear factor-?b in the biology and treatment of multiple myeloma, Seminars in Oncology, vol.28, issue.6, pp.626-633, 2001. ,
DOI : 10.1016/S0093-7754(01)90036-3
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and Ikappa Balpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis, Blood, vol.101, issue.3, pp.1053-1062, 2003. ,
DOI : 10.1182/blood-2002-05-1320
Nuclear factor-??B and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis, Blood, vol.103, issue.8, pp.3175-3184, 2004. ,
DOI : 10.1182/blood-2003-06-2151
Interleukin-21 is a growth and survival factor for human myeloma cells, Blood, vol.99, issue.10, pp.3756-3762, 2002. ,
DOI : 10.1182/blood.V99.10.3756
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells, Immunity, vol.10, pp.105-115, 1999. ,
Libermann, 6-dependent human myeloma cell lines, European Journal of Immunology, vol.27, pp.3332-3340 ,
Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis, Leukemia, vol.18, issue.3, pp.628-635, 2004. ,
DOI : 10.1038/sj.leu.2403269
Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop, Blood, vol.88, pp.3972-3986, 1996. ,
Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors, Leukemia, vol.14, issue.1, pp.188-197, 2000. ,
DOI : 10.1038/sj.leu.2401632
NF-??B as a Therapeutic Target in Multiple Myeloma, Journal of Biological Chemistry, vol.277, issue.19, pp.16639-16647, 2002. ,
DOI : 10.1074/jbc.M200360200
MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo, Clinical Cancer Research, vol.12, pp.5887-5894, 2006. ,
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone, Blood, vol.103, issue.8, pp.3148-3157, 2004. ,
DOI : 10.1182/blood-2003-06-1984
URL : https://hal.archives-ouvertes.fr/inserm-00129502
Analysis of expression of nuclear factor kappaB (NF-kappaB) in multiple myeloma: downregulation of NF-kappaB induces apoptosis, British Journal of Haematology, vol.44, issue.2, pp.279-286, 2001. ,
DOI : 10.1006/scbi.1997.0058
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells, Blood, vol.107, issue.12, pp.4907-4916, 2006. ,
DOI : 10.1182/blood-2005-08-3531
A gp130 interleukin-6 transducerdependent SCID model of human multiple myeloma, Blood, vol.91, pp.4727-4737, 1998. ,
Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor, Clinical Cancer Research, vol.11, 1974. ,
Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells, Journal of Immunology, vol.163, pp.514-524, 1999. ,
A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V, Journal of Immunological Methods, vol.184, issue.1, pp.39-51, 1995. ,
DOI : 10.1016/0022-1759(95)00072-I
Phosphorylation of NF-??B and I??B proteins: implications in cancer and inflammation, Trends in Biochemical Sciences, vol.30, issue.1, pp.43-52, 2005. ,
DOI : 10.1016/j.tibs.2004.11.009
Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB, Nature Medicine, vol.5, pp.412-417, 1999. ,
Interleukin-6 dependence of advanced malignant plasma cell dyscrasias, Cancer, vol.78, issue.6, pp.1373-1376, 1992. ,
DOI : 10.1002/1097-0142(19920315)69:6<1373::AID-CNCR2820690612>3.0.CO;2-1
Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma, Blood, vol.83, pp.3654-3663, 1994. ,